Grundlæggende statistik
| LEI | 529900438MNY6TZ5ZY17 |
| CIK | 1385145 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Cellcom Israel Ltd.
SEC Filings (Chronological Order)
Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.
| February 14, 2023 |
IL:CEL / Cellcom Israel Ltd / Phoenix Holdings Ltd. - SC 13G/A Passive Investment SC 13G/A 1 zk2329232.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.2)* Cellcom Israel Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share (Title of Class of Securities) M2196U109 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check th |
|
| February 9, 2022 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For February 9, 2022 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| February 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15F CERTIFICATION OF A FOREIGN PRIVATE ISSUER’S TERMINATION OF REGISTRATION OF A CLASS OF SECURITIES UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ITS TERMINATION OF THE DUTY TO FILE REPORTS UNDER SECTION 13(a) OR SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-33271 Cellcom |
|
| February 9, 2022 |
As filed with the Securities and Exchange Commission on February 9, 2022. As filed with the Securities and Exchange Commission on February 9, 2022. Registration No. 333-141639 Registration No. 333-184955 Registration No. 333-206338 Registration No. 333-231633 Registration No. 333-238827 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 REGISTRATION NO. 333-141639 POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 REGI |
|
| February 9, 2022 |
As filed with the Securities and Exchange Commission on February 9, 2022. S-8 POS 1 zk2227237.htm S-8 POS As filed with the Securities and Exchange Commission on February 9, 2022. Registration No. 333-141639 Registration No. 333-184955 Registration No. 333-206338 Registration No. 333-231633 Registration No. 333-238827 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 REGISTRATION NO. 333-141639 POST-EFFECTIVE |
|
| February 9, 2022 |
As filed with the Securities and Exchange Commission on February 9, 2022. As filed with the Securities and Exchange Commission on February 9, 2022. Registration No. 333-141639 Registration No. 333-184955 Registration No. 333-206338 Registration No. 333-231633 Registration No. 333-238827 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 REGISTRATION NO. 333-141639 POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 REGI |
|
| February 9, 2022 |
CELLCOM ISRAEL LTD. TO TERMINATE REGISTRATION AND SEC REPORTING OBLIGATIONS Exhibit 1 CELLCOM ISRAEL LTD. TO TERMINATE REGISTRATION AND SEC REPORTING OBLIGATIONS Netanya, Israel, February 9, 2022 ? Cellcom Israel Ltd. (the "Company?) (TASE: CEL) hereby announces that it intends to terminate the registration of its Ordinary Shares, par value NIS 0.01 per share, and its reporting obligations under Section 15(d) of the Securities Exchange Act of 1934, as amended, with the Un |
|
| February 9, 2022 |
As filed with the Securities and Exchange Commission on February 9, 2022. As filed with the Securities and Exchange Commission on February 9, 2022. Registration No. 333-141639 Registration No. 333-184955 Registration No. 333-206338 Registration No. 333-231633 Registration No. 333-238827 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 REGISTRATION NO. 333-141639 POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 REGI |
|
| February 9, 2022 |
As filed with the Securities and Exchange Commission on February 9, 2022. S-8 POS 1 zk2227236.htm S-8 POS As filed with the Securities and Exchange Commission on February 9, 2022. Registration No. 333-141639 Registration No. 333-184955 Registration No. 333-206338 Registration No. 333-231633 Registration No. 333-238827 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 REGISTRATION NO. 333-141639 POST-EFFECTIVE |
|
| February 2, 2022 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For February 2, 2022 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| February 2, 2022 |
IL:CEL / Cellcom Israel Ltd / Migdal Insurance & Financial Holdings Ltd. - SC 13G Passive Investment SC 13G 1 zk2227128.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. ) (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) Under the Securities Exchange Act of 1934 CELLCOM ISRAEL LTD (Name of Issuer) Ordinary Shares (Title of Class o |
|
| February 1, 2022 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For February 1, 2022 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| January 31, 2022 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For January 31, 2022 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| January 27, 2022 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For January 27, 2022 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| January 25, 2022 |
6-K 1 zk2227113.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For January 25, 2022 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| January 24, 2022 |
6-K 1 zk2227086.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For January 24, 2022 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| January 24, 2022 |
6-K 1 zk2227088.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For January 24, 2022 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| January 18, 2022 |
6-K 1 zk2227063.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For January 18, 2022 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| January 6, 2022 |
6-K 1 zk2227024.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For January 6, 2022 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant f |
|
| January 5, 2022 |
6-K 1 zk2227019.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For January 5, 2022 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant f |
|
| January 3, 2022 |
6-K 1 zk2227007.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For January 3, 2022 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant f |
|
| December 30, 2021 |
6-K 1 zk2127000.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 30, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| December 22, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 22, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| December 20, 2021 |
6-K 1 a2126976.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 20, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| December 20, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 20, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| December 9, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 9, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| December 8, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 8, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| December 6, 2021 |
6-K 1 zk2126926.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 6, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| November 29, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 29, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| November 26, 2021 |
6-K 1 zk2126886.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 26, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| November 26, 2021 |
6-K 1 zk2126889.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 26, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| November 23, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 23, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| November 23, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 23, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| November 22, 2021 |
6-K 1 zk2126870.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 22, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| November 16, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 16, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| November 12, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 6-K 1 zk2126811.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 11, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| November 12, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 11, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| November 4, 2021 |
IL:CEL / Cellcom Israel Ltd / DISCOUNT INVESTMENT CORP LTD - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7) Cellcom Israel Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share (Title of Class of Securities) M2196U-10-9 (CUSIP Number) Larisa Cohen, Adv. Discount Investment Corporation Ltd. ToHa Building, 27th floor, 114 Igal Alon St., Tel Aviv 674 |
|
| November 2, 2021 |
6-K 1 zk2126733.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 2, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| November 1, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 1, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| October 26, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For October 26, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| October 25, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For October 25, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| October 22, 2021 |
6-K 1 zk2126679.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For October 22, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| October 18, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For October 18, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| October 13, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For October 13, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| October 13, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For October 13, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| October 13, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For October 13, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| October 7, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For October 7, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| October 6, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For October 6, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| September 27, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For September 27, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file ann |
|
| September 7, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For September 7, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| September 7, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For September 7, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| September 2, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 6-K 1 zk2126545.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For September 2, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| September 2, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For September 2, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| September 1, 2021 |
6-K 1 zk2126534.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For September 1, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| August 23, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 22, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| August 16, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 16, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| August 13, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 6-K 1 zk2126463.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 13, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant f |
|
| August 12, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 12, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| August 9, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 9, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| August 9, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 9, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| August 3, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 3, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| August 2, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 2, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| July 29, 2021 |
6-K 1 zk2126348.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For July 29, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant fil |
|
| July 27, 2021 |
6-K 1 zk2126334.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For July 27, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant fil |
|
| July 20, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For July 20, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| July 19, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For July 19, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| July 7, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For July 7, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| July 6, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For July 6, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| July 6, 2021 |
6-K 1 zk2126260.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For July 6, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant file |
|
| July 6, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For July 6, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| June 28, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June 28, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| June 28, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June 28, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| June 21, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June 21, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| June 16, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June 16, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| June 14, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June 14, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| June 14, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June 14, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| June 7, 2021 |
6-K 1 zk2126171.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June 7, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant file |
|
| June 3, 2021 |
6-K 1 zk2126155.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June 3, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant file |
|
| June 2, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June 2, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| June 2, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June 2, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| May 27, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 27, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| May 24, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 24, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| May 20, 2021 |
6-K 1 zk2126057.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 20, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant file |
|
| May 20, 2021 |
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 20, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| May 6, 2021 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 6, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual rep |
|
| April 28, 2021 |
Exhibit 12.2 I, Shai Amsalem, Chief Financial Officer of the Company, certify that: 1. I have reviewed this annual report on Form 20-F of Cellcom Israel Ltd; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not mi |
|
| April 28, 2021 |
Exhibit 13.1 The certification set forth below is being submitted in connection with the Annual Report on Form 20-F of Cellcom Israel Ltd. for the year ended December 31, 2020 (the ?Report?) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the ?Exchange Act?) and Section 1350 of Chapter 63 of Title 18 of the United States Code. Avi Gabbay, |
|
| April 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20?F ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O |
|
| April 28, 2021 |
Consent of Independent Registered Public Accounting Firm - Kesselman & Kesselman* Exhibit 15.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-238827, No. 333-141639, No. 333-184955, No. 333-206338 and No. 333-231633) of Cellcom Israel Ltd. of our report dated March 17, 2021 relating to the consolidated financial statements and the effectiveness of internal control o |
|
| April 28, 2021 |
Consent of Independent Registered Public Accounting Firm - Somekh Chaikin * EX-15.1 8 exhibit15-1.htm EXHIBIT 15.1 Exhibit 15.1 Somekh Chaikin KPMG Millennium Tower 17 Ha’arba’a Street, PO Box 609 Tel Aviv 61006, Israel +972 3 684 8000 Consent of Independent Registered Public Accounting Firm The Board of Directors Cellcom Israel Ltd: We consent to the incorporation by reference in the registration statements (No. 333-238827, No. 333-141639, No. 333-184955, No. 333-206338 |
|
| April 28, 2021 |
TRANSLATION FROM HEBREW THE BINDING VERSION IS THE HEBREW VERSION Exhibit 4.13 TRANSLATION FROM HEBREW THE BINDING VERSION IS THE HEBREW VERSION State of Israel Ministry of Communications General License to Cellcom Israel Ltd. for the Provision of mobile radio telephone services by the cellular method (cellular) Combined Version, as at March, 2021 1 TRANSLATION FROM HEBREW THE BINDING VERSION IS THE HEBREW VERSION General License for Cellcom Israel Ltd. Award of |
|
| April 28, 2021 |
Description of Securities Registered under Section 12 of the Exchange Act* Exhibit 2.1.1 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT As of December 31, 2020, Cellcom Israel Ltd. (the ?Company? or ?Cellcom?) had the following series of securities registered pursuant to Section 12(b) of the Act: Title of each class Ticker symbol Name of each exchange on which registered Ordinary Shares, par value NIS 0.01 each CEL New York Stock Exchange Capit |
|
| April 28, 2021 |
Exhibit 12.1 I, Avi Gabbay, Chief Executive Officer of the Company, certify that: 1. I have reviewed this annual report on Form 20-F of Cellcom Israel Ltd; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misl |
|
| April 20, 2021 |
Current Report of Foreign Issuer - 6-K 6-K 1 zk2125895.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For April 20, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant fi |
|
| April 20, 2021 |
Current Report of Foreign Issuer - 6-K 6-K 1 zk2125896.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For April 20, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant fi |
|
| April 12, 2021 |
Current Report of Foreign Issuer - 6-K 6-K 1 zk2125870.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For April 12, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant fi |
|
| April 7, 2021 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For April 7, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| April 5, 2021 |
Current Report of Foreign Issuer - 6-K 6-K 1 zk2125841.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For April 5, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant fil |
|
| March 29, 2021 |
Current Report of Foreign Issuer - 6-K 6-K 1 zk2125827.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 29, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant fi |
|
| March 25, 2021 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 25, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| March 22, 2021 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 22, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| March 17, 2021 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 17, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| March 16, 2021 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 16, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| March 15, 2021 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 15, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| March 3, 2021 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 3, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| March 3, 2021 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 3, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| February 17, 2021 |
Current Report of Foreign Issuer - 6-K 6-K 1 zk2125616.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For February 17, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. ) (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) Under the Securities Exchange Act of 1934 CELLCOM ISRAEL LTD (Name of Issuer) Ordinary Shares (Title of Class of Securities) M2196U109 (CUSIP |
|
| February 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.1)* Cellcom Israel Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share (Title of Class of Securities) M2196U109 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| February 11, 2021 |
Current Report of Foreign Issuer - 6-K 6-K 1 zk2125547.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For February 11, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| February 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* Cellcom Israel Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share (Title of Class of Securities) M2196U109 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th |
|
| February 9, 2021 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For February 9, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| February 8, 2021 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For February 8, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| February 8, 2021 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For February 8, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| February 1, 2021 |
Current Report of Foreign Issuer - 6-K 6-K 1 zk2125446.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For February 1, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| January 29, 2021 |
UNITEDSTATES OMB APPROVAL SECURITIES AND EXCHANGE COMMlSSJON OMB Number: 3235-0080 Washington, D. |
|
| January 20, 2021 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For January 20, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| January 19, 2021 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For January 19, 2021 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| December 9, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 9, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| December 4, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 4, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| November 27, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 26, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| November 24, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 24, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| November 23, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 23, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| November 23, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 23, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 4250708 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file an |
|
| November 23, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 22, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| November 16, 2020 |
Current Report of Foreign Issuer - 6K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 16, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| November 9, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 9, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| October 21, 2020 |
CEL / Cellcom Israel, Ltd. / DISCOUNT INVESTMENT CORP LTD - SC 13D/A Activist Investment SC 13D/A 1 zk2025016.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6) Cellcom Israel Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share (Title of Class of Securities) M2196U-10-9 (CUSIP Number) Larisa Cohen, Adv. Discount Investment Corporation Ltd. ToHa Building, 27th floo |
|
| October 15, 2020 |
Current Report of Foreign Issuer - 6-K 6-K 1 zk2024999.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For October 15, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| October 13, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For October 12, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| September 28, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For September 27, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file ann |
|
| September 23, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For September 23, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file ann |
|
| September 15, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For September 15, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file ann |
|
| September 14, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For September 14, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file ann |
|
| September 14, 2020 |
EX-99 2 exhibit1.htm EXHIBIT 1 Exhibit 1 [Unofficial Translation] December 12, 2019 Powers of Signature in The Phoenix Holdings Ltd. (hereinafter: the "Company") In accordance with a resolution of the Board of Directors of the Company, the powers of signatures in the Company as of December 12, 2019, are as follows: General Rights of Signature 1. The signature of the Chairman of the Board of Direct |
|
| September 14, 2020 |
IL:CEL / Cellcom Israel Ltd / Phoenix Holdings Ltd. - SC 13G Passive Investment SC 13G 1 zk2024911.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* Cellcom Israel Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share (Title of Class of Securities) M2196U109 (CUSIP Number) September 6, 2020 (Date of Event Which Requires Filing of this Statement) Check the ap |
|
| September 9, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For September 9, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| August 26, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 26, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| August 17, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 17, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| August 17, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 17, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 4250708 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| August 13, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 13, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| August 13, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 13, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| August 12, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 12, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| August 12, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 12, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| August 6, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 6, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| August 4, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 4, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| July 27, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For July 27, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| July 27, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For July 27, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| July 16, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For July 16, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| June 16, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June 16, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| June 16, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June 16, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| June 16, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June 16, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 4250708 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| June 10, 2020 |
Current Report of Foreign Issuer - 6-K 6-K 1 zk2024561.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June 10, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant fil |
|
| June 9, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June 9, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| June 8, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For June7, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual rep |
|
| June 1, 2020 |
Cellcom Israel, Ltd. 2015 Share Incentive Plan, as amended (filed herewith) EXHIBIT 99.1 CELLCOM ISRAEL, LTD. 2015 SHARE INCENTIVE PLAN A. NAME AND PURPOSE 1. Name: This plan, as amended from time to time, shall be known as the “Cellcom Israel, Ltd. 2015 Share Incentive Plan”. 2. Purpose: The purpose and intent of the Plan is to provide incentives to employees, directors, consultants and/or contractors of the Company and its Affiliates, by providing them with opportunitie |
|
| June 1, 2020 |
As filed with the Securities and Exchange Commission on June 1, 2020 Registration No. |
|
| May 21, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 21, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 4250708 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| May 20, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 20, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| May 14, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 14, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| May 12, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 12, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| May 11, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 10, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| May 11, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 11, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| May 11, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 11, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| May 6, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 6, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual rep |
|
| May 5, 2020 |
Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 5, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual rep |
|
| April 13, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For April 13, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| March 26, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 26, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| March 25, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 25, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| March 23, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K 6-K 1 zk2024184.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 23, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant fi |
|
| March 23, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K 6-K 1 zk2024193.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 23, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant fi |
|
| March 23, 2020 |
Exhibit 12.1 I, Avi Gabbay, Chief Executive Officer of the Company, certify that: 1. I have reviewed this annual report on Form 20-F of Cellcom Israel Ltd; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misl |
|
| March 23, 2020 |
Exhibit 13.1 The certification set forth below is being submitted in connection with the Annual Report on Form 20-F of Cellcom Israel Ltd. for the year ended December 31, 2019 (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code. Avi Gabbay, |
|
| March 23, 2020 |
Description of Securities Registered under Section 12 of the Exchange Act* Exhibit 2.1.1 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT As of December 31, 2019, Cellcom Israel Ltd. (the “Company” or “Cellcom”) had the following series of securities registered pursuant to Section 12(b) of the Act: Title of each class Ticker symbol Name of each exchange on which registered Ordinary Shares, par value NIS 0.01 each CEL New York Stock Exchange Capit |
|
| March 23, 2020 |
Consent of Independent Registered Public Accounting Firm - Keselman & Keselman* Exhibit 15.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-141639, No. 333-184955, No. 333-206338 and No. 333-231633) of Cellcom Israel Ltd. of our report dated March 23, 2020 relating to the consolidated financial statements and the effectiveness of internal control over financial re |
|
| March 23, 2020 |
TRANSLATION FROM HEBREW THE BINDING VERSION IS THE HEBREW VERSION Exhibit 4.16 TRANSLATION FROM HEBREW THE BINDING VERSION IS THE HEBREW VERSION Memorandum of Understanding That was signed in Tel Aviv on the 18th of February 2020 By and between: Cellcom Israel Ltd. (hereinafter: the “Purchaser” or “Cellcom”) 10 Hagavish St. Netanya of the first part, And: 1. Electra Consumer Products (1970) Ltd. (hereinafter: “Electra”) 1 Hasapir St. Rishon Lezion 2. Gil Sharon |
|
| March 23, 2020 |
TRANSLATION FROM HEBREW THE BINDING VERSION IS THE HEBREW VERSION Exhibit 4.13 TRANSLATION FROM HEBREW THE BINDING VERSION IS THE HEBREW VERSION State of Israel Ministry of Communications General License to Cellcom Israel Ltd. for the Provision of mobile radio telephone services by the cellular method (cellular) Combined Version, as at March, 2020 1 TRANSLATION FROM HEBREW THE BINDING VERSION IS THE HEBREW VERSION General License for Cellcom Israel Ltd. Award of |
|
| March 23, 2020 |
Exhibit 12.2 I, Shlomi Fruhling, Chief Financial Officer of the Company, certify that: 1. I have reviewed this annual report on Form 20-F of Cellcom Israel Ltd; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not |
|
| March 23, 2020 |
Consent of Independent Registered Public Accounting Firm - Somekh Chaikin * EX-15.1 9 exhibit15-1.htm EXHIBIT 15.1 Exhibit 15.1 Somekh Chaikin KPMG Millennium Tower 17 Ha’arba’a Street, PO Box 609 Tel Aviv 61006, Israel +972 3 684 8000 Consent of Independent Registered Public Accounting Firm The Board of Directors Cellcom Israel Ltd: We consent to the incorporation by reference in the registration statements (No. 333-141639, No. 333-184955, No. 333-206338 and No. 333-2316 |
|
| March 23, 2020 |
CEL / Cellcom Israel, Ltd. 20-F - - 20-F 20-F 1 zk2024169.htm 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20–F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE |
|
| March 18, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 18, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| March 18, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 18, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| March 17, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 17, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| March 9, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 8, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| March 9, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 8, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| March 9, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 9, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| March 5, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 5, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| March 5, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 5, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| March 4, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 4, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| February 27, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For February 27, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| February 24, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For February 23, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| February 18, 2020 |
CEL / Cellcom Israel, Ltd. / Psagot Investment House Ltd. - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 8)* Cellcom Israel Ltd (Name of Issuer) Ordinary Shares, per value NIS 0.01 per share (Title of Class o |
|
| February 18, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For February 16, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| February 18, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For February 18, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| February 18, 2020 |
EX-99 2 exhibit1.htm EXHIBIT 1 Exhibit 1 Attorney's Certification I the undersigned, Lee-Tal Yakir, Attorney at Psagot Investment House Ltd, hereby certify as follows: 1. The above composition of signatures is binding on Psagot Investment House Ltd. in respect of the attached report. 2. The above authorized signatories signed this document before me and were identified by me in person according to |
|
| February 12, 2020 |
CEL / Cellcom Israel, Ltd. / MENORA MIVTACHIM HOLDINGS LTD. - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* Cellcom Israel Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share (Title of Class of Securities) M2196U109 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th |
|
| February 6, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For February 06, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| February 6, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For February 06, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| January 28, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For January 28, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 4250708 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file ann |
|
| January 21, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For January 21, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| January 6, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For January 6, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| January 2, 2020 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For January 2, 2020 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| December 31, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 31, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| December 30, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 30, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| December 27, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K 6-K 1 zk1923766.htm 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 27, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant |
|
| December 26, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 26, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| December 19, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 19, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| December 18, 2019 |
CEL / Cellcom Israel, Ltd. / DISCOUNT INVESTMENT CORP LTD - SC 13D/A Activist Investment SC 13D/A 1 zk1923746.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5) Cellcom Israel Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share (Title of Class of Securities) M2196U-10-9 (CUSIP Number) Larisa Cohen, Adv. Discount Investment Corporation Ltd. ToHa Building, 27th floo |
|
| December 5, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 5, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| December 5, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 5, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| December 2, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For December 2, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| November 27, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 27 ,2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 4250708 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file an |
|
| November 21, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 21, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| November 12, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For November 10, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| October 30, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For October 30, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| September 24, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For September 24, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file ann |
|
| September 24, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For September 24, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file ann |
|
| September 23, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For September 23, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file ann |
|
| September 9, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For September 9, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| August 15, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 15 ,2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 4250708 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annu |
|
| August 5, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 5, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| August 5, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 5, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| August 1, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For August 1, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| July 31, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For July 31, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| July 16, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For July 16, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| July 10, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For July 10, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| July 8, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For July 8, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| May 28, 2019 |
CEL / Cellcom Israel, Ltd. 6-K - Current Report of Foreign Issuer - 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 28, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 4250708 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| May 21, 2019 |
Cellcom Israel, Ltd. 2015 Share Incentive Plan, as amended (filed herewith) EX-99.1 5 exhibit99-1.htm EXHIBIT 99.1 Exhibit 99.1 CELLCOM ISRAEL, LTD. 2015 SHARE INCENTIVE PLAN A. NAME AND PURPOSE 1. Name: This plan, as amended from time to time, shall be known as the “Cellcom Israel, Ltd. 2015 Share Incentive Plan”. 2. Purpose: The purpose and intent of the Plan is to provide incentives to employees, directors, consultants and/or contractors of the Company and its Affiliat |
|
| May 21, 2019 |
CEL / Cellcom Israel, Ltd. S-8 - - S-8 As filed with the Securities and Exchange Commission on May 21, 2019 Registration No. |
|
| May 14, 2019 |
CEL / Cellcom Israel, Ltd. 6-K Current Report of Foreign Issuer 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 14, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| May 13, 2019 |
CEL / Cellcom Israel, Ltd. 6-K Current Report of Foreign Issuer 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 13, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual re |
|
| May 6, 2019 |
CEL / Cellcom Israel, Ltd. 6-K Current Report of Foreign Issuer 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For May 6, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual rep |
|
| April 15, 2019 |
CEL / Cellcom Israel, Ltd. 6-K (Current Report of Foreign Issuer) FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For April 15, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| April 1, 2019 |
CEL / Cellcom Israel, Ltd. 6-K (Current Report of Foreign Issuer) FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For April 1, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual r |
|
| April 1, 2019 |
Exhibit 12.2 I, Shlomi Fruhling, Chief Financial Officer of the Company, certify that: 1. I have reviewed this Amendment No. 1 to the annual report on Form 20-F of Cellcom Israel Ltd; and 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which suc |
|
| April 1, 2019 |
CEL / Cellcom Israel, Ltd. 20-F/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20–F/A (Amendment No. 1) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECUR |
|
| April 1, 2019 |
Exhibit 12.1 I, Nir Sztern, Chief Executive Officer of the Company, certify that: 1. I have reviewed this Amendment No. 1 to the annual report on Form 20-F of Cellcom Israel Ltd; and 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such sta |
|
| April 1, 2019 |
Consent of Independent Registered Public Accounting Firm - Somekh Chaikin* Exhibit 15.1 Somekh Chaikin KPMG Millennium Tower 17 Ha’arba’a Street, PO Box 609 Tel Aviv 61006, Israel +972 3 684 8000 Consent of Independent Registered Public Accounting Firm The Board of Directors Cellcom Israel Ltd: We consent to the incorporation by reference in the registration statements (No. 333-141639, No. 333-184955 and No. 333-206338) on Form S-8 of Cellcom Israel Ltd. (“the Company”) |
|
| March 19, 2019 |
CEL / Cellcom Israel, Ltd. 6-K (Current Report of Foreign Issuer) FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 19, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 42140 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual |
|
| March 18, 2019 |
CEL / Cellcom Israel, Ltd. 6-K (Current Report of Foreign Issuer) FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For March 18, 2019 Commission File Number: 001-33271 CELLCOM ISRAEL LTD. 10 Hagavish Street Netanya, Israel 4250708 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annua |
|
| March 18, 2019 |
Exhibit 13.1 The certification set forth below is being submitted in connection with the Annual Report on Form 20-F of Cellcom Israel Ltd. for the year ended December 31, 2018 (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code. Nir Sztern, |
|
| March 18, 2019 |
Letter of Somekh Chaikin addressed to the SEC pursuant to Item 16F * EX-15.3 9 exhibit15-3.htm EXHIBIT 15.3 Exhibit 15.3 Somekh Chaikin KPMG Millennium Tower 17 Ha’arba’a Street, PO Box 609 Tel Aviv 61006, Israel +972 3 684 8000 March 18, 2019 Securities and Exchange Commission Washington, D.C. 20549 Ladies and Gentlemen: We are currently a principal accountant for Cellcom Israel Ltd. and its subsidiaries (the "Company") and, under the date of March 25, 2018, we re |
|
| March 18, 2019 |
Consent of Independent Registered Public Accounting Firm - Somekh Chaikin * EX-15.1 7 exhibit15-1.htm EXHIBIT 15.1 Exhibit 15.1 Somekh Chaikin KPMG Millennium Tower 17 Ha’arba’a Street, PO Box 609 Tel Aviv 61006, Israel +972 3 684 8000 Consent of Independent Registered Public Accounting Firm The Board of Directors Cellcom Israel Ltd: We consent to the incorporation by reference in the registration statements (No. 333-141639, No. 333-184955 and No. 333-206338) on Form S-8 |
|
| March 18, 2019 |
Consent of Independent Registered Public Accounting Firm - Keselman & Keselman* EX-15.2 8 exhibit15-2.htm EXHIBIT 15.2 Exhibit 15.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-141639, No. 333-184955 and 333-206338) of Cellcom Israel Ltd. of our report dated March 18, 2019 relating to the consolidated financial statements and the effectiveness of internal contro |
|
| March 18, 2019 |
TRANSLATION FROM HEBREW THE BINDING VERSION IS THE HEBREW VERSION Exhibit 4.13 TRANSLATION FROM HEBREW THE BINDING VERSION IS THE HEBREW VERSION State of Israel Ministry of Communications General License to Cellcom Israel Ltd. for the Provision of mobile radio telephone services by the cellular method (cellular) Combined Version, as at March 1, 2019 1 TRANSLATION FROM HEBREW THE BINDING VERSION IS THE HEBREW VERSION General License for Cellcom Israel Ltd. Award |
|
| March 18, 2019 |
Exhibit 12.2 I, Shlomi Fruhling, Chief Financial Officer of the Company, certify that: 1. I have reviewed this annual report on Form 20-F of Cellcom Israel Ltd; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not |
|
| March 18, 2019 |
Exhibit 12.1 I, Nir Sztern, Chief Executive Officer of the Company, certify that: 1. I have reviewed this annual report on Form 20-F of Cellcom Israel Ltd; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misl |
|
| March 18, 2019 |
CEL / Cellcom Israel, Ltd. 20-F 20-F 1 zk1922798.htm 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20–F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE |
